Literature DB >> 1356048

Criteria for diagnosis of familial amyotrophic lateral sclerosis. European FALS Collaborative Group.

M Swash1, N Leigh.   

Abstract

Clinical criteria for the diagnosis of motor neuron disease, agreed at the inaugural meeting of the European Familial Amyotrophic Lateral Sclerosis Collaborative Group, are described. The criteria are derived from those developed for the study of sporadic amyotrophic lateral sclerosis, and allow the inclusion of certain recognized clinical sub-types of familial amyotrophic lateral sclerosis. They will require testing for consistency and sensitivity.

Entities:  

Mesh:

Year:  1992        PMID: 1356048     DOI: 10.1016/0960-8966(92)90020-7

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

Authors:  P J Massman; J Sims; N Cooke; L J Haverkamp; V Appel; S H Appel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 2.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

3.  Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  K Ray-Chaudhuri; C Smith; A C Gough; N Novak; V Chamoun; C R Wolf; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

Review 4.  Motor neuron disease.

Authors:  P N Leigh; K Ray-Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

Review 5.  Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics.

Authors:  Ranjeet Prasad Dash; R Jayachandra Babu; Nuggehally R Srinivas
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

Review 6.  [Genetics of amyotrophic lateral sclerosis].

Authors:  A Hübers; J H Weishaupt; A C Ludolph
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

7.  The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study.

Authors:  I C Newsom-Davis; R A Lyall; P N Leigh; J Moxham; L H Goldstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

8.  Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis.

Authors:  N Meucci; E Nobile-Orazio; G Scarlato
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

9.  Motor neuron disease in a defined English population: estimates of incidence and mortality.

Authors:  G Dean; M Quigley; M Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

10.  Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study.

Authors:  P R Talbot; P J Goulding; J J Lloyd; J S Snowden; D Neary; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.